Join the Testim group to help and get support from people like you.
Testim News
Testosterone Tied to Incidence, Progression of Metabolic Syndrome
THURSDAY, July 11, 2024 – Testosterone is associated with a greater risk for development and progression of metabolic syndrome, particularly in transmasculine individuals, according to a study...
Male Birth Control Gel Shows Promise in Trial
MONDAY, June 3, 2024 – A new hormonal gel could one day be a potential form of birth control for men, researchers reported Sunday. “The development of a safe, highly effective and reliably r...
All-Cause Mortality Risk Up for Men With Low Testosterone
MONDAY, May 13, 2024 – The risk for all-cause mortality is increased for men with low testosterone, high luteinizing hormone, or very low estradiol, according to a review published online May 14 in...
1 in 3 Trans Masculine People Taking Testosterone Can Still Ovulate: Study
FRIDAY, Feb. 23, 2024 – A third of trans masculine people who have undergone testosterone therapy and have stopped menstruating are still ovulating, a new study suggests. That means they remain at...
Testosterone Treatment Does Not Cut Fracture Incidence in Men With Hypogonadism
THURSDAY, Jan. 18, 2024 – Testosterone treatment does not result in a lower incidence of clinical fractures among middle-aged and older men with hypogonadism, according to a study published in the...
Testosterone Therapy for Transgender Patients May Be Safer Than Thought
TUESDAY, Nov. 28, 2023 – Transgender people transitioning to male (transmasculine) identity typically take testosterone therapy as part of the process. There have been worries that the treatment ...
Hematocrit Within Normal Range With Testosterone Gender-Affirming Therapy
MONDAY, Nov. 27, 2023 – For people using testosterone as gender-affirming hormone therapy (GAHT), mean hematocrit varies from 41.84 to 45.68 percent, which is within the normal range, according to a...
Testosterone Efficacious for Correcting Anemia in Middle-Aged Men
MONDAY, Oct. 30, 2023 – Testosterone replacement therapy (TRT) is efficacious for correcting anemia among middle-aged and older men with hypogonadism and anemia, according to a study published...
FDA Medwatch Alert: FDA Alerts Customers to Voluntary Recall of Compounded Drugs Due to Sterility Issues by Drug Depot, LLC, dba APS Pharmacy
April 26, 2022 --FDA is alerting patients, health care professionals, veterinarians, and animal owners/caretakers about a voluntary recall by Drug Depot, LLC, doing business as APS Pharmacy, of...
FDA Medwatch Alert: Testosterone and Other Anabolic Androgenic Steroids (AAS): FDA Statement - Risks Associated With Abuse and Dependence
ISSUE: FDA approved class-wide labeling changes for all prescription testosterone products, adding a new Warning and updating the Abuse and Dependence section to include new safety information from...
FDA Medwatch Alert: Testosterone Products: FDA/CDER Statement - Risk of Venous Blood Clots
[Posted 06/20/2014] ISSUE: FDA notified health professionals and their medical care organizations that it is requiring the manufacturers of all approved testosterone products to include a warning ...
FDA Medwatch Alert: Testosterone Products: Drug Safety Communication - FDA Investigating Risk of Cardiovascular Events
[Posted 01/31/2014] ISSUE: FDA is investigating the risk of stroke, heart attack, and death in men taking FDA-approved testosterone products. We have been monitoring this risk and decided to...
FDA Medwatch Alert: University Compounding Pharmacy Injection Products: Recall - Lack of Sterility Assurance
ISSUE: University Compounding Pharmacy is voluntarily recalling products, including Testosterone Cypionate (Sesame Oil), Testosterone Cypionate/Testosterone Proprionate, and PGE-1 NS, for injection, ...
FDA Medwatch Alert: Olympia Pharmacy Sterile Compounded Products: Recall - Concerns About Sterility Assurance
[Posted 05/30/2013] ISSUE: Lowlite Investments d/b/a Olympia Pharmacy ("Lowlite") notified the public of a voluntary multi-state recall of all sterile drug products compounded by the pharmacy that ...
FDA Medwatch Alert: Testosterone gel products (AndroGel and Testim)
FDA notified healthcare professionals that it will require two prescription topical testosterone gel products, AndroGel 1% and Testim 1%, to include a boxed warning on the products’ labels after r...